Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 2Completed 2Terminated 1

Sponsor Class

OTHER 3NIH 2

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Gastrointestinal 55Lymphoid 5Other 2Head & Neck 2Genitourinary 2Classical hematology 2Breast 2Thoracic 1Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Lymphoma 2983Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Lymphoma, Non-Hodgkin 2269Leukemia, Lymphocytic, Chronic, B-Cell 1992Lymphoma, Follicular 1848Lymphoma, Large B-Cell, Diffuse 1785Leukemia 1341Hodgkin Disease 1293Lymphoma, Mantle-Cell 1193Leukemia, Myeloid, Acute 979Burkitt Lymphoma 956Multiple Myeloma 866Lymphoma, B-Cell, Marginal Zone 853Recurrence 841Lymphoma, B-Cell 756Myelodysplastic Syndromes 683Neoplasms 595Lymphoma, T-Cell, Cutaneous 543Waldenstrom Macroglobulinemia 514Lymphoma, Large-Cell, Immunoblastic 490Mycosis Fungoides 438Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 414Lymphoma, Large-Cell, Anaplastic 390Sezary Syndrome 364Lymphoma, T-Cell, Peripheral 352Hematologic Neoplasms 351Leukemia, Myelogenous, Chronic, BCR-ABL Positive 334Myeloproliferative Disorders 328Neoplasms, Plasma Cell 309Blast Crisis 284

Interventions

ledipasvir, sofosbuvir drug combination 2Sofosbuvir 1Ribavirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Hepatitis C × Lymphoid × Clear all
NCT00341705 2019-12-17

The Second Multicenter Hemophilia Cohort Study

National Institutes of Health Clinical Center (CC)

Completed
2,565 enrolled
Classical hematologyGastrointestinalLymphoid

Acquired Immunodeficiency Syndrome, Hemophilia A, Hepatitis C, Carcinoma, Hepatocellular, Lymphoma, Non-Hodgkin, Neoplasms, Hepatic Insufficiency

NCT02717949 2019-01-08

Optimal

University of Texas Southwestern Medical Center

Phase 4 Terminated
1 enrolled
Lymphoid

Hepatitis C, Liver Diseases, Lymphoma, Non-Hodgkin

NCT03261349 2017-08-25

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

National Taiwan University Hospital

Phase 2 Unknown
21 enrolled
Lymphoid

Hepatitis C, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Lymphoma, B-Cell, Marginal Zone

NCT00342641 2017-07-02

Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers

National Institutes of Health Clinical Center (CC)

Completed
815,000 enrolled
Head & NeckLymphoidPlasma cell

Hepatitis C, Lymphoma, Multiple Myeloma, Thyroiditis

NCT02588560 2015-10-28

Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy

Chang Gung Memorial Hospital

Unknown
38 enrolled
Lymphoid

Hepatitis C, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡